Branka Čučević

1.6k total citations · 1 hit paper
16 papers, 1.2k citations indexed

About

Branka Čučević is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Branka Čučević has authored 16 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pulmonary and Respiratory Medicine, 9 papers in Oncology and 2 papers in Surgery. Recurrent topics in Branka Čučević's work include Lung Cancer Treatments and Mutations (7 papers), Lung Cancer Research Studies (6 papers) and Lung Cancer Diagnosis and Treatment (4 papers). Branka Čučević is often cited by papers focused on Lung Cancer Treatments and Mutations (7 papers), Lung Cancer Research Studies (6 papers) and Lung Cancer Diagnosis and Treatment (4 papers). Branka Čučević collaborates with scholars based in Croatia, Poland and Austria. Branka Čučević's co-authors include Christoph Zielinski, Maciej Krzakowski, Thomas Brodowicz, Tudor–Eliade Ciuleanu, Valentina Tzekova, Sung Hyun Yang, Jayaprakash Madhavan, William J. John, Patrick Peterson and Chandra P. Belani and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and The Lancet Oncology.

In The Last Decade

Branka Čučević

14 papers receiving 1.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Maintenance pemetrexed plus best supportive care versus placebo plus best supportive care for non-small-cell lung cancer: a randomised, double-blind, phase 3 study

2009 832 citations Tudor–Eliade Ciuleanu, Thomas Brodowicz et al. The Lancet profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Branka Čučević Croatia	7	1.1k	840	153	120	99	16	1.2k
Symantha Melemed United States	12	1.2k 1.1×	990 1.2×	236 1.5×	190 1.6×	123 1.2×	16	1.4k
R. Corre France	17	816 0.8×	541 0.6×	84 0.5×	113 0.9×	102 1.0×	88	1.0k
Giuseppe Comella Italy	16	642 0.6×	817 1.0×	163 1.1×	112 0.9×	88 0.9×	42	1.1k
C. Decroisette France	11	524 0.5×	493 0.6×	130 0.8×	112 0.9×	103 1.0×	50	706
Luigi Maiorino Italy	18	706 0.7×	879 1.0×	115 0.8×	231 1.9×	121 1.2×	47	1.2k
D. Brisgand France	5	666 0.6×	639 0.8×	155 1.0×	79 0.7×	50 0.5×	8	840
Arnd Nusch Germany	14	476 0.5×	437 0.5×	126 0.8×	215 1.8×	41 0.4×	50	729
Shaan Dudani Canada	14	536 0.5×	420 0.5×	271 1.8×	246 2.0×	141 1.4×	48	765
Haruko Daga Japan	16	611 0.6×	594 0.7×	181 1.2×	182 1.5×	58 0.6×	92	911
Katarzyna Pogoda Poland	11	392 0.4×	512 0.6×	89 0.6×	176 1.5×	44 0.4×	53	721

Countries citing papers authored by Branka Čučević

Since Specialization

Citations

This map shows the geographic impact of Branka Čučević's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Branka Čučević with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Branka Čučević more than expected).

Fields of papers citing papers by Branka Čučević

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Branka Čučević. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Branka Čučević. The network helps show where Branka Čučević may publish in the future.

Co-authorship network of co-authors of Branka Čučević

This figure shows the co-authorship network connecting the top 25 collaborators of Branka Čučević. A scholar is included among the top collaborators of Branka Čučević based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Branka Čučević. Branka Čučević is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Jakopović, Marko, et al.. (2018). [CANCER PATIENTS FOLLOW-UP – CROATIAN SOCIETY FOR MEDICAL ONCOLOGY CLINICAL GUIDELINES Part V: melanoma, sarcomas, central nerve system tumors, lung cancer].. PubMed. 139(1-2). 17–23. 2 indexed citations

Jakopović, Marko, et al.. (2017). P1.07-013 Treatment Related Side Effects of Oral Topotecan in Small Cell Lung Cancer. Journal of Thoracic Oncology. 12(1). S703–S703.

Samaržija, Miroslav, et al.. (2016). Cancer-related inflammation as predicting tool for treatment outcome in locally advanced and metastatic non-small cell lung cancer. Journal of Thoracic Disease. 8(7). 1497–1503. 6 indexed citations

Jakopović, Marko, Ana Hečimović, Branka Čučević, et al.. (2016). The effect of emergency presentation on survival of lung cancer patients.. Journal of Clinical Oncology. 34(15_suppl). e18041–e18041. 1 indexed citations

Čučević, Branka, et al.. (2015). Talc pleurodesis improves survival of patients with malignant pleural effusions: case-control study. Wiener klinische Wochenschrift. 127(23-24). 963–969. 8 indexed citations

Jakopović, Marko, et al.. (2014). Safety and efficacy of erlotinib in patients with squamous cell lung cancer. 44. 2722. 2 indexed citations

Popović‐Grle, Sanja, et al.. (2013). Waist circumference does not correlate with functional lung capacity in moderate and severe chronic obstructive pulmonary disease.. PubMed. 52(1). 69–77. 2 indexed citations

Belani, Chandra P., Thomas Brodowicz, Tudor–Eliade Ciuleanu, et al.. (2012). Quality of life in patients with advanced non-small-cell lung cancer given maintenance treatment with pemetrexed versus placebo (H3E-MC-JMEN): results from a randomised, double-blind, phase 3 study. The Lancet Oncology. 13(3). 292–299. 56 indexed citations

Ciuleanu, Tudor–Eliade, Thomas Brodowicz, Christoph Zielinski, et al.. (2009). Maintenance pemetrexed plus best supportive care versus placebo plus best supportive care for non-small-cell lung cancer: a randomised, double-blind, phase 3 study. The Lancet. 374(9699). 1432–1440. 832 indexed citations breakdown →

10.

Brodowicz, Thomas, Maciej Krzakowski, Matjaž Zwitter, et al.. (2006). Cisplatin and gemcitabine first-line chemotherapy followed by maintenance gemcitabine or best supportive care in advanced non-small cell lung cancer: A phase III trial. Lung Cancer. 52(2). 155–163. 256 indexed citations

11.

Rudan, Igor, Zrinka Biloglav, Ariana Vorko-Jović, et al.. (2006). Effects of inbreeding, endogamy, genetic admixture, and outbreeding on human health: a (1001 Dalmatians) study.. PubMed. 47(4). 601–10. 38 indexed citations

12.

Boras, Vanja Vučićević, et al.. (2005). Candidiasis associated with thymoma and myasthenia gravis. 41(3). 56–59.

13.

Čučević, Branka, et al.. (2005). Gemcitabine in the first and second-line chemotherapy of advanced non-small cell lung cancer.. PubMed. 29(2). 583–8. 2 indexed citations

14.

Wenczl, M., Thomas Brodowicz, Valentina Tzekova, et al.. (2003). O-88 Gemcitabine and cisplatin (GC) +/-subsequent maintenance therapy with single-agent gemcitabine in advanced non-small cell lung cancer (NSCLC): Preliminary results of a randomized trial of the Central European Cooperative Oncology Group (CECOG). Lung Cancer. 41. S29–S29. 7 indexed citations

15.

Čučević, Branka, et al.. (1992). [Tracheobronchomegaly (Mounier-Kuhn syndrome)].. PubMed. 43(1-2). 78–80. 1 indexed citations

16.

Čučević, Branka, et al.. (1992). [Comparative analysis of bronchoalveolar lavage and transbronchial biopsy in pulmonary sarcoidosis].. PubMed. 43(1-2). 106–8. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact